Skip to Main Content

Molecular diagnostics has quickly become one of the leading global technologies for infectious disease testing. As such, clinicians and physicians rely on the results generated from these tests for accurate patient diagnoses. The field is constantly growing and evolving to meet the demands of infectious disease testing, but what remains constant is the importance for laboratories to maintain rigorous quality management practices, including quality control, to help ensure reliable test results.

Since the onset of the SARS-CoV-2 pandemic, many clinical laboratories acquired new molecular diagnostic platforms to reduce send out costs and expedite test results. While COVID-19 testing is still a priority, many laboratories are faced with the question: what next? How can we get the most out of our new platforms while juggling supply chain issues and limited staffing?

This webinar will help you to better understand QC for infectious disease testing. We will discuss the basic principles and practices of using QC materials in laboratories. From there, we will explore the types of molecular tests you might be using and delve into the benefits of using third-party quality controls. You will also get a glimpse into ZeptoMetrix NATtrol™ molecular quality control development and how the company is leading efforts on QC for SARS-CoV-2 testing.

AlertAlertBrowse fileDownload fileFileImagePdfWordTextExcelPowerpointArchiveCsvAudioVideoSpinnerCalendarReturn arrowMinusVisibleInvisibleVisibleInvisibleConfigure